阿奇霉素两种给药方案治疗小儿肺炎支原体肺炎的成本及效果分析  

Treating Mycoplasma Pneumoniae Pneumonia with Azithromycin by Continuous Intravenous Drip or Sequential Therapy Cost-effectiveness Analysis

作　　者：王苑[1] 曾荣仕[1] 朱湛华[1] 

机构地区：[1]广东医学院附属医院,广东湛江524001

出　　处：《实用医技杂志》2007年第20期2758-2759,共2页Journal of Practical Medical Techniques

摘　　要：目的：评价亚思达阿奇霉素两种不同给药方案治疗小儿肺炎支原体肺炎的成本-效果。方法：将64例小儿肺炎支原体肺炎患者随机分为A、B组，各32例，其中A组采用阿奇霉素注射液连续静脉滴注，B组采用阿奇霉素注射彬阿奇霉素干混悬剂序贯给药，并对两种方案进行成本-效果分析。结果：两组在有效率及不良反应发生率方面差异无显著性（P〉0．05），但A组的治疗成本却明显高于B组（P〈0．01），且成本-效果A组高于B组。结论：对小儿肺炎支原体肺炎。采用序贯给药治疗不但安全、有效，而且更加经济、合理。Objective To evaluate the cost-effectiveness of azithromycin for mycoplasma pneumoniae pneumonia by continuous intravenous drip or sequential therapy. Methods A total of 64 patients with mycoplasma pneumoniae pneumonia groups： 32 cases in group A were assigned to receive azithromycin injection by continuous intravenous drip, another 32 cases in group B to receive azithromycin injection/suspension by sequential design. Cost-effectiveness analysis was performed on the 2 groups. Results No significant difference was noted between 2 groups in effective rates and incidences of ADRs （ P 〉 0.05 ）, but the treatment cost in group A was significantly higher than in group B（P 〈0.01 ） ,and the cost-effecliveness ratio in group A was also higher than in group B. Conclusion The sequential therapy of azithromycin is safe, effective, economical and rational for mycoplasma pneumoniae pneumonia.

关 键 词：肺炎支原体肺炎 阿奇霉素 连续静脉滴注 序贯给药 成本-效果分析 

分 类 号：R725.6[医药卫生—儿科]